1.Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer

Xu, DH, Luo, YH, Wan     More...

Xu, DH, Luo, YH, Wang, P, Li, JX, Ma, LR, Huang, J, Zhang, H, Yang, XM, Li, LQ, Zheng, YH, Fang, G, Yan, PY     Less

FRONTIERS IN ONCOLOGY[2234-943X], Published 2023, Volume 13,

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  4.7 

2.The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance

Li, RZ, Wang, XR, Wa     More...

Li, RZ, Wang, XR, Wang, J, Xie, C, Wang, XX, Pan, HD, Meng, WY, Liang, TL, Li, JX, Yan, PY, Wu, QB, Liu, L, Yao, XJ, Leung, ELH     Less

FRONTIERS IN ONCOLOGY[2234-943X], Published 2022, Volume 12,

收錄情况： WOS

WOS核心合集引用: 21  2022影響因子:  4.7  发表年影響因子:  4.7